Episode 19: Debunking Bupe Diversion Myths with Molly Doernberg

35:27
 
Share
 

Manage episode 233256129 series 2321723
By Christopher Moraff, Troy Farah, Zachary Seigel, Christopher Moraff, Troy Farah, and Zachary Seigel. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
If you ask many, many people whose lives have been upended by opioids, buprenorphine is a life saver. It can literally cut the risk of a fatal overdose by half or more in folks who have an opioid addiction. Also known as Subutex or Suboxone, buprenorphine is one of the three FDA approved medications to treat what’s formally known as opioid use disorder. It’s a partial agonist at opioid receptors, relieving cravings but with far less risk for overdose than other opioids like heroin, which are full agonists.

Zachary Siegel, Troy Farah and Christopher Moraff speak with Molly Doernberg, a grad student at Yale School of Public Health, who co-authored a recent paper called “Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?” which was published in the journal Substance Abuse last April. They discuss what buprenorphine is, why people take it, and why stigma and fears that buprenorphine may be used illicitly are actually contributing to more overdose deaths.

Follow Narcotica on Facebook, Twitter and support us on Patreon. Your support is appreciated!
Read Doernberg’s paper here: https://doi.org/10.1080/08897077.2019.1572052 and follow her on Twitter.
Producers: Christopher Moraff, Troy Farah, Zachary Siegel
Co-Producer: Aaron Ferguson
Music: Glass Boy and Aaron Ferguson
Image Credit: Chris Moraff / Edit by Troy Farah

The post Episode 19: Debunking Bupe Diversion Myths with Molly Doernberg appeared first on Narcotica.

64 episodes